Q6MTU2 AF NFT

Valine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeidznz3nc4ikw4vkunjvg4hatmnu7sinu7hduo4e7cku2p3mfutvie/metadata.json
IPFS of structure file: 
bafybeibcdcecnmj2pvo2ymix3xsdbzmrpfpziomd6mv2tk4krddbvsfeyq/AF-Q6MTU2-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xB44F19a0cb161828322eEEd13F55d4C3C34938d2
First NFT owner address (bech32): 
genesis1k383ngxtzcvzsv3wamgn74w5c0p5jwxjy9e46q
Current NFT ID #454981 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
454981
Accession (UniProt):
Q6MTU2
Name::
Valine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
Mycoplasma mycoides subsp. mycoides SC (strain PG1)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q6MTU2 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q6MTU2|SYV_MYCMS Valine--tRNA ligase OS=Mycoplasma mycoides subsp. mycoides SC (strain PG1) OX=272632 GN=valS PE=3 SV=1 MKKQLNPKYDHLQVEKDKYQYWLDKNLFKADINSNKPKFSIILPPPNVTGKLHIGHAWDTSLQDAIIRFKKLTGYDTLFLPGMDHSGISTQVKVEAKLKQQGIDKNKLGREKFLLEAWKWKEEYANIIRKQWAKLGLSLDYSTEKFTLDEDINQIVKEIFVKFYNDQIIYKDKQIVNWDPEQKTAISNVEVIYKETQSKMYYFKYILEDSNEYLTVATTRPETMFADQCLVVNPNDSRYQKYINKKVINPVNKQVIPIISDEYVDIEFGTGVMKCTPAHDLNDYHLGIKHNLKMPICLNIDGSVNQLGGKYQGLDRFVARKKIIKNAIKEDLFVKEEDIINQVGFSERSNAIVEPYLSDQWFVKMDKFKNMVIDLQNSDNKINFYPNRFSDVLNRWMTDAHDWCISRQLWWGHQIPCWYHKKTNEMYVGINPPSDIENWTQDQDVLDTWFSSGLWAFSTLLNNKGLESEYFKNYFPTSVLVTGYDIIFFWVARMIFQTLEYTKQIPFKDVLIHGLVRDESNRKMSKSLGNGIDPMDVINNNGCDSLRLFLLTNSTPGQDIRYSNEKILASWNFINKLWNASRYVFLNLDEDFKFDPNFYKTDLEITNQWILTQLSKTQTYVYEKMNKYEFSLAGNHLWDFVWNKYCSWYIEFSKVNLNNDKFTHQTKQTLFYVLKEILIMLHPLIPFVSEEIYLNMMLKESILLEQWTNLNSNYDTSFIDDVIKMITSIREFRNTKNIKNDVCLSVNISNTNQNHTKLFKKHFDQIYNFLFNFCNTKLVDEAIKNKTSLSIDEYFIEIANDSFINKNELIKELEQKQNYLNNEITRSQKILNNQEFIKKAKPEKIQSEKIKYQNYLDQLQAIKDKLKELTND